Go Pro
LON:BVXP

Bioventix (BVXP) Share Price, News & Analysis

Bioventix logo
GBX 1,477 -33.00 (-2.19%)
As of 09/15/2026 12:14 PM Eastern

About Bioventix Stock (LON:BVXP)

Advanced

Key Stats

Today's Range
1,450
1,600
50-Day Range
1,471.11
1,800
52-Week Range
1,300
2,700
Volume
21,277 shs
Average Volume
10,358 shs
Market Capitalization
£77.17 million
P/E Ratio
10.51
Dividend Yield
9.38%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.

Receive BVXP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bioventix and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BVXP Stock News Headlines

Jon Najarian's #1 Energy Trade for 2026
Jon Najarian says he's never been more excited about an energy opportunity. SpaceX just went public at over $2 trillion, with Anthropic and OpenAI preparing IPOs of their own. But Najarian's top pick isn't an IPO. It's a small American company with a $6 billion market cap powering Elon Musk's newest venture, dubbed the Infinite Power Grid. The full story is laid out in his newly released presentation.tc pixel
Peter Harrison Spends UK£39k On Bioventix Stock
Pleasing Signs As A Number Of Insiders Buy Bioventix Stock
See More Headlines

BVXP Stock Analysis - Frequently Asked Questions

Bioventix's stock was trading at GBX 1,905 at the beginning of 2026. Since then, BVXP shares have decreased by 22.5% and is now trading at GBX 1,477.

Bioventix PLC (LON:BVXP) issued its earnings results on Monday, March, 30th. The biotechnology company reported $69.38 earnings per share (EPS) for the quarter. The biotechnology company had revenue of $6.16 billion for the quarter. Bioventix had a trailing twelve-month return on equity of 65.83% and a net margin of 59.30%.

Shares of BVXP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Bioventix investors own include Lancashire (LRE), Avast (AVST), Victrex (VCT), boohoo group (BOO), Tullow Oil (TLW), Airbnb (ABNB) and Avon Protection (AVON).

Company Calendar

Last Earnings
3/30/2026
Today
9/15/2026

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
LON:BVXP
CIK
N/A
Fax
N/A
Employees
12
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX 140.52
Trailing P/E Ratio
10.51
Forward P/E Ratio
8.88
P/E Growth
N/A
Net Income
£8.12 million
Net Margins
59.30%
Pretax Margin
N/A
Return on Equity
65.83%
Return on Assets
54.07%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
6.12
Quick Ratio
5.50

Sales & Book Value

Annual Sales
£12.54 million
Price / Sales
6.15
Cash Flow
GBX 47.82 per share
Price / Cash Flow
30.89
Book Value
GBX 229.94 per share
Price / Book
6.42

Miscellaneous

Outstanding Shares
5,225,000
Free Float
N/A
Market Cap
£77.17 million
Optionable
Not Optionable
Beta
0.56
7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

This page (LON:BVXP) was last updated on 9/16/2026 by MarketBeat.com Staff.
From Our Partners